C. Fissore

Sign up to set email alerts
|
10Publications
27Citation Statements Received
100Citation Statements Given
How they've been cited
52
0
27
0
How they cite others
116
10
75
15
Publications
Order By: Most citations

Gefitinib (ZD1839): Therapy in selected patients with non-small cell lung cancer (NSCLC)?

Dongiovanni
1
,
Lilleri
2
,
Barone
3
et al. 2008
Lung Cancer
21
0
12
0
View full textAdd to dashboardCite

Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial

Dongiovanni
1
,
Buffoni
2
,
Berruti
3
et al. 2005
Cancer Chemother Pharmacol
11
0
6
0
View full textAdd to dashboardCite
show abstract

Fractionated dose of cisplatin (CDDP) and vinorelbine (VNB) chemotherapy for elderly patients with advanced non-small cell lung cancer: Phase II trial

Buffoni
1
,
Dongiovanni
2
,
Barone
3
et al. 2006
Lung Cancer
10
0
6
0
View full textAdd to dashboardCite

Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer

Dongiovanni
1
,
Fissore
2
,
Berruti
3
et al. 2005
Lung Cancer
8
0
3
0
View full textAdd to dashboardCite

Patterns of metastasis, response to treatment and survival in young patients with advanced non small cell lung cancer (NSCLC)

Addeo
1
,
Dongiovanni
2
,
Birocco
3
et al. 2004
JCO
0
0
0
0
View full textAdd to dashboardCite

1310 POSTER A phase II study with cisplatin (cddp) and gemcitabine (gem) in elderly patients with advanced non-small cell lung cancer

Buffoni1,
Dongiovanni2,
Barone3
et al. 2007
European Journal of Cancer Supplements
0
0
0
0
View full textAdd to dashboardCite

Second-line chemotherapy with weekly paclitaxel and gemcitabine in platinum-etoposide pretreated patients with small cell lung cancer (SCLC): A single institution phase II trial

Dongiovanni
1
,
Buffoni
2
,
Dongiovanni
3
et al. 2004
JCO
2
0
0
0
View full textAdd to dashboardCite

P-542 Carboplatin (C) and docetaxel (D) in the second-line treatment of non-small cell lung cancer (NSCLC) patients pretreated with platinum-based regimens. A Phase II trial

Numico1,
Buffoni2,
Dongiovanni3
et al. 2005
Lung Cancer
0
0
0
0
View full textAdd to dashboardCite
12
scite logo

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Product
Browser ExtensionAssistant by sciteCitation Statement SearchReference CheckVisualizationsDashboardsExplore JournalsExplore OrganizationsExplore FundersEmbedding BadgeEmbedding Citation SearchPricing
Resources
BlogHelp & FAQAccessibility StatementAPI TermsFor Universities & GovernmentsFor ResearchersFor PublishersFor Corporate, Pharma & EnterpriseAuthor MarketingBecome an AffiliateGet an organization trial or quotescite Data & Services
About
News & PressCareersRead our PaperCoverage

BlogTerms and ConditionsAPI TermsPrivacy PolicyContactCookie PreferencesDo Not Sell or Share My Personal Information

Copyright © 2024 scite LLC. All rights reserved.

Made with 💙 for researchers

Part of the Research Solutions Family.